Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nerudia

Nerudia
2013 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
$141M LATEST DEAL AMOUNT
Description

Manufacturer of nicotine products designed to provide scientific support to characterise customers' products within a single regulated facility. The company's nicotine products include electronic cigarettes, e-liquids and other related products, enabling the customers to bring quality products to the market and at the same time guide them through the regulatory pathways for these novel products.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Commercial Services
Other Industries
Other Consumer Non-Durables
Parent Company
Primary Office
  • Wellington House
  • Physics Road, Speke
  • Liverpool L24 9HP
  • England, United Kingdom

+44 0151 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nerudia’s full profile, request a free trial.

Nerudia Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 23-Oct-2017 $141M 00000 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Nerudia Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Epiphany Capital Venture Capital Minority 000 0000 000000 0

Nerudia Executive Team (3)

Name Title Board
Seat
Contact
Info
Chris Lord Co-Founder & Chief Executive Officer
Andy Gaunt Chief Commercial Officer
David Newns Co-Founder